Brightgene Bio-medical Technology Co Ltd
688166
Company Profile
Business description
Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. The company develops macrolides, peptides, polysaccharides, heterocycles, azoles, azines, phenyl ethers, tetracyclines, and production of non-pharmaceutical macrolides, peptides, polysaccharides, heterocycles, azoles, azines, benzene Ethers, tetracyclines.
Contact
Xinghu Street, Industrial Park
Building C25-C28, Bio-Nano Park, No. 218
Suzhou215123
CHNT: +86 51262620988
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
1,155
Stocks News & Analysis
stocks
Best and worst performing ASX sectors of 2024
Exploring the ASX sectors that moved the market this year.
stocks
2 ASX companies with the traits of a long-term winner
Two companies that show promising signs of handsomely rewarding shareholders.
video
Our outlook for 2025
Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,519.70 | 48.20 | 0.57% |
| CAC 40 | 7,282.69 | 10.37 | 0.14% |
| DAX 40 | 19,848.77 | 35.98 | -0.18% |
| Dow JONES (US) | 43,325.80 | 28.77 | 0.07% |
| FTSE 100 | 8,136.99 | 34.27 | 0.42% |
| HKSE | 20,061.59 | 36.70 | -0.18% |
| NASDAQ | 20,020.36 | 10.77 | -0.05% |
| Nikkei 225 | 40,028.74 | 460.68 | 1.16% |
| NZX 50 Index | 13,144.55 | 69.81 | 0.53% |
| S&P 500 | 6,037.59 | 2.45 | -0.04% |
| S&P/ASX 200 | 8,262.80 | 41.90 | 0.51% |
| SSE Composite Index | 3,392.14 | 5.94 | -0.17% |